Node Context · New Drugs & Biosimilars
KOSPI · 128940

Hanmi Pharm. Co., Ltd.

New Drugs & Biosimilars · Individual stock relative-strength trackerLive reactions on X
Price
₩411,000
Intraday · 11:31 KST
1D Change
-9.27%
Intraday · 11:31 KST
Market Cap
₩5.3T
Intraday · 11:31 KST
StockRank
42.9

Hanmi Pharm. Co., Ltd. (128940) is listed on KOSPI. StockRank shown here is based on New Drugs & Biosimilars. The same stock can score differently under a different node. Its weekly moving averages are mixed, neither aligned nor inverted. The sections below cover its price history, earnings and cash flow, foreign ownership, short-selling balance, and National Pension Service holdings.

Node correlation is strong (0.7 or above), while ETF weight is weak (0.3 or below).

RS Norm?
0.45
Momentum Norm?
0.46
Volume Surge?
0.52
Node Corr?
0.73
ETF Weight?
0.03
Trading Value
₩48.7B
FCF Yield?
+3.73%
Revenue Growth TTM?
+12.93%
Market OpinionLast 5

Over the last 6 months, brokers raised their target 6 times and cut it 3 times versus their previous call.

DateFirmRatingTarget PriceTitleReport
26-09-10KB SecuritiesBuyNEW650,000 →로슈와 한 배를 탔다
26-09-07KB SecuritiesPositive— →Biopharma Deals & News Weekly
26-08-31KB SecuritiesPositive— →Biopharma Deals & News Weekly
26-08-27Shinhan SecuritiesBuy650,000 ↑K-비만, 전설의 시작
26-08-25DS투자증권Buy720,000 ↑비만 Next generation: 근육 보존제 UCN-2
Recent Signal Tapelatest 8 sessions

StockRank fell 0.9 points over the last 8 sessions.

DateRankRSMOMVOLCORR
26-10-1342.90.450.460.520.73
26-10-1244.20.500.460.510.71
26-10-0836.90.440.430.510.71
26-10-0737.50.480.440.450.58
26-10-0637.00.470.450.410.61
26-10-0240.40.420.450.400.60
26-10-0141.50.420.480.430.66
26-09-3043.80.470.510.420.74
NPS Stake ChangesLast 5
As ofSourceShares HeldStake %Change
26-10-06Officer/insider1,300,40510.15%↑
26-10-02Major holder1,230,7759.61%↓
26-09-29Officer/insider1,286,14210.04%↑
26-08-07Quarterly filing1,231,1369.61%↓
26-08-03Officer/insider1,264,2559.87%↓
Data source: National Pension Service (NPS) Fund Disclosure (quarterly) + DART e-disclosure (real-time)
ETF Holdings PerformanceHolding weight 5%+ (top 50 sector ETFs + top 50 by trading value, 100 total)

The stock's 20-session return of −8.4% is 3.6pp ahead of the average of the 5 ETFs that hold it (−12.0%).

ETFCode20D ReturnWeight
ACE Life Asset Shareholder Value Active494330-6.86%6.84%
TIGER 200 Healthcare227540-9.99%9.78%
RISE Bio TOP10 Active0000Z0-13.55%7.97%
HANARO Bio Korea Active498050-14.42%6.16%
KoAct Bio Healthcare Active462900-15.38%7.12%